# Modulation of Gut Microbiota to Enhance Health and Immunity

> **NCT04884776** · NA · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 453 (actual)

## Conditions studied

- Gut Microbiota
- COVID-19 Vaccine

## Interventions

- **DIETARY_SUPPLEMENT:** Microbiome immunity formula
- **DIETARY_SUPPLEMENT:** Active placebo

## Key facts

- **NCT ID:** NCT04884776
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-05-31
- **Target enrollment:** 453 (ACTUAL)
- **Last updated:** 2022-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04884776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04884776, "Modulation of Gut Microbiota to Enhance Health and Immunity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04884776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*